These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 20873795

  • 1. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM.
    J Med Chem; 2010 Oct 28; 53(20):7377-91. PubMed ID: 20873795
    [Abstract] [Full Text] [Related]

  • 2. Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.
    Adabala PJ, LeGresley EB, Bance N, Niikura M, Pinto BM.
    J Org Chem; 2013 Nov 01; 78(21):10867-77. PubMed ID: 24090215
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
    Kongkamnerd J, Cappelletti L, Prandi A, Seneci P, Rungrotmongkol T, Jongaroonngamsang N, Rojsitthisak P, Frecer V, Milani A, Cattoli G, Terregino C, Capua I, Beneduce L, Gallotta A, Pengo P, Fassina G, Miertus S, De-Eknamkul W.
    Bioorg Med Chem; 2012 Mar 15; 20(6):2152-7. PubMed ID: 22342267
    [Abstract] [Full Text] [Related]

  • 4. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A, Mohan S, Zheng RB, Pinto BM, Cairo CW.
    Bioorg Med Chem; 2011 May 01; 19(9):2817-22. PubMed ID: 21489803
    [Abstract] [Full Text] [Related]

  • 5. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Niikura M, Bance N, Mohan S, Mario Pinto B.
    Antiviral Res; 2011 Jun 01; 90(3):160-3. PubMed ID: 21443905
    [Abstract] [Full Text] [Related]

  • 6. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS, Wang SQ, Chou KC.
    Biochem Biophys Res Commun; 2007 Oct 19; 362(2):525-31. PubMed ID: 17707775
    [Abstract] [Full Text] [Related]

  • 7. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM.
    Biophys Chem; 2009 Mar 19; 140(1-3):35-8. PubMed ID: 19117662
    [Abstract] [Full Text] [Related]

  • 8. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.
    J Med Chem; 2014 Oct 23; 57(20):8445-58. PubMed ID: 25255388
    [Abstract] [Full Text] [Related]

  • 9. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S.
    Antiviral Res; 2009 Apr 23; 82(1):51-8. PubMed ID: 19428595
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
    Calligari PA, Kneller GR, Giansanti A, Ascenzi P, Porrello A, Bocedi A.
    Biophys Chem; 2009 Apr 23; 141(1):117-23. PubMed ID: 19195766
    [Abstract] [Full Text] [Related]

  • 11. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
    Malaisree M, Rungrotmongkol T, Nunthaboot N, Aruksakunwong O, Intharathep P, Decha P, Sompornpisut P, Hannongbua S.
    Amino Acids; 2009 Oct 23; 37(4):725-32. PubMed ID: 19002747
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH.
    J Am Chem Soc; 2007 Oct 03; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract] [Full Text] [Related]

  • 13. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW, Jo WH.
    Eur J Med Chem; 2010 Feb 03; 45(2):536-41. PubMed ID: 19914748
    [Abstract] [Full Text] [Related]

  • 14. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M, Martin SR, Birge M, Carbain B, Streicher H.
    Org Biomol Chem; 2011 Aug 21; 9(16):5625-9. PubMed ID: 21720632
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
    Jia R, Zhang J, Ai W, Ding X, Desta S, Sun L, Sun Z, Ma X, Li Z, Wang D, Huang B, Zhan P, Liu X.
    Eur J Med Chem; 2019 Sep 15; 178():64-80. PubMed ID: 31176096
    [Abstract] [Full Text] [Related]

  • 16. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
    Hitaoka S, Harada M, Yoshida T, Chuman H.
    J Chem Inf Model; 2010 Oct 25; 50(10):1796-805. PubMed ID: 20863103
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC.
    J Med Chem; 1998 Jul 02; 41(14):2451-60. PubMed ID: 9651151
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
    Liu Y, Jing F, Xu Y, Xie Y, Shi F, Fang H, Li M, Xu W.
    Bioorg Med Chem; 2011 Apr 01; 19(7):2342-8. PubMed ID: 21382719
    [Abstract] [Full Text] [Related]

  • 19. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
    D'Ursi P, Chiappori F, Merelli I, Cozzi P, Rovida E, Milanesi L.
    Biochem Biophys Res Commun; 2009 Jun 12; 383(4):445-9. PubMed ID: 19371724
    [Abstract] [Full Text] [Related]

  • 20. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
    Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J.
    J Med Chem; 1998 Mar 12; 41(6):798-807. PubMed ID: 9526556
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.